Early Vitrectomy Within Three Days of Symptom Onset is Associated with Greater Visual Recovery in Exogenous Infectious Endophthalmitis: A Retrospective Cohort Study.

IF 1.7 4区 医学 Q2 OPHTHALMOLOGY
Chia-An Hsu, Meng-Jou Chen, Chang-Chi Weng, Yu-Bai Chou, Yi-Ming Huang, Tai-Chi Lin, Shih-Jen Chen, De-Kuang Hwang
{"title":"Early Vitrectomy Within Three Days of Symptom Onset is Associated with Greater Visual Recovery in Exogenous Infectious Endophthalmitis: A Retrospective Cohort Study.","authors":"Chia-An Hsu, Meng-Jou Chen, Chang-Chi Weng, Yu-Bai Chou, Yi-Ming Huang, Tai-Chi Lin, Shih-Jen Chen, De-Kuang Hwang","doi":"10.1080/09273948.2026.2739465","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>To evaluate whether pars plana vitrectomy (PPV) performed within 72 hours of symptom onset is associated with greater visual recovery compared with initial tap-and-inject therapy in exogenous infectious endophthalmitis.</p><p><strong>Methods: </strong>Retrospective cohort study of consecutive patients with exogenous infectious endophthalmitis at a tertiary referral centre (2009-2018). Eyes were classified according to whether PPV was performed within 72 hours of symptom onset, irrespective of preceding intravitreal antibiotics injection; eye without PPV during this window comprised the injection-first comparison group. The primary endpoint was logMAR best corrected visual acuity (BCVA) change at three months; secondary endpoints were absolute BCVA and BCVA change at one year. Multivariable linear regression identified independent outcome predictors.</p><p><strong>Results: </strong>Eighty-four eyes were included (20 early PPV; 64 tap-and-inject). Despite worse baseline BCVA in the early PPV group (2.18 ± 0.36 vs. 1.62 ± 0.82 logMAR), three-month BCVA improvement was significantly greater (-1.28 ± 0.78 vs. -0.64 ± 0.89 logMAR; <i>p</i> = 0.01). The benefit persisted at one year (-1.51 ± 0.77 vs. -0.79 ± 0.96 logMAR; <i>p</i> = 0.012). Multivariable regression confirmed early PPV as an independent predictor of better three-month BCVA change (β =  -0.647; <i>p</i> = 0.003) and greater one-year improvement (β =  -0.578; <i>p</i> = 0.022).</p><p><strong>Conclusion: </strong>Early vitrectomy within a 72-hour window is associated with significantly greater visual recovery in exogenous infectious endophthalmitis, independent of presenting BCVA. Both presenting visual acuity and time from symptom onset should jointly inform treatment decisions, supporting a management approach that might extend beyond conventional EVS criteria.</p>","PeriodicalId":19406,"journal":{"name":"Ocular Immunology and Inflammation","volume":" ","pages":"1-7"},"PeriodicalIF":1.7000,"publicationDate":"2026-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ocular Immunology and Inflammation","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/09273948.2026.2739465","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: To evaluate whether pars plana vitrectomy (PPV) performed within 72 hours of symptom onset is associated with greater visual recovery compared with initial tap-and-inject therapy in exogenous infectious endophthalmitis.

Methods: Retrospective cohort study of consecutive patients with exogenous infectious endophthalmitis at a tertiary referral centre (2009-2018). Eyes were classified according to whether PPV was performed within 72 hours of symptom onset, irrespective of preceding intravitreal antibiotics injection; eye without PPV during this window comprised the injection-first comparison group. The primary endpoint was logMAR best corrected visual acuity (BCVA) change at three months; secondary endpoints were absolute BCVA and BCVA change at one year. Multivariable linear regression identified independent outcome predictors.

Results: Eighty-four eyes were included (20 early PPV; 64 tap-and-inject). Despite worse baseline BCVA in the early PPV group (2.18 ± 0.36 vs. 1.62 ± 0.82 logMAR), three-month BCVA improvement was significantly greater (-1.28 ± 0.78 vs. -0.64 ± 0.89 logMAR; p = 0.01). The benefit persisted at one year (-1.51 ± 0.77 vs. -0.79 ± 0.96 logMAR; p = 0.012). Multivariable regression confirmed early PPV as an independent predictor of better three-month BCVA change (β =  -0.647; p = 0.003) and greater one-year improvement (β =  -0.578; p = 0.022).

Conclusion: Early vitrectomy within a 72-hour window is associated with significantly greater visual recovery in exogenous infectious endophthalmitis, independent of presenting BCVA. Both presenting visual acuity and time from symptom onset should jointly inform treatment decisions, supporting a management approach that might extend beyond conventional EVS criteria.

外源性感染性眼内炎症状出现3天内早期玻璃体切除与更大的视力恢复相关:一项回顾性队列研究。
目的:评价外源性感染性眼内炎患者在症状出现72小时内行玻璃体切除(PPV)是否与最初的轻拍注射治疗有更大的视力恢复相关。方法:对2009-2018年三级转诊中心连续外源性感染性眼内炎患者进行回顾性队列研究。根据是否在症状出现的72小时内进行过PPV,而不考虑之前是否进行过玻璃体内抗生素注射,对眼睛进行分类;在此窗口期间,没有PPV的眼睛组成了先注射的对照组。主要终点为3个月时logMAR最佳矫正视力(BCVA)变化;次要终点为绝对BCVA和一年内BCVA变化。多变量线性回归确定了独立的结果预测因子。结果:共纳入84只眼(早期PPV 20只,轻叩注射64只)。尽管早期PPV组基线BCVA较差(2.18±0.36比1.62±0.82 logMAR),但三个月BCVA改善明显更大(-1.28±0.78比-0.64±0.89 logMAR; p = 0.01)。获益持续一年(-1.51±0.77 vs -0.79±0.96 logMAR; p = 0.012)。多变量回归证实,早期PPV是较好的3个月BCVA变化(β = -0.647; p = 0.003)和较好的1年改善(β = -0.578; p = 0.022)的独立预测因子。结论:外源性感染性眼内炎患者在72小时内进行早期玻璃体切除术可显著提高视力恢复,与是否存在BCVA无关。表现出的视力和症状出现的时间应共同为治疗决策提供信息,支持可能超出传统EVS标准的管理方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
6.20
自引率
15.20%
发文量
285
审稿时长
6-12 weeks
期刊介绍: Ocular Immunology & Inflammation ranks 18 out of 59 in the Ophthalmology Category.Ocular Immunology and Inflammation is a peer-reviewed, scientific publication that welcomes the submission of original, previously unpublished manuscripts directed to ophthalmologists and vision scientists. Published bimonthly, the journal provides an international medium for basic and clinical research reports on the ocular inflammatory response and its control by the immune system. The journal publishes original research papers, case reports, reviews, letters to the editor, meeting abstracts, and invited editorials.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书